Graft versus host disease Market
Jul 04, 2025
GvHD Drugs Treatment Market Heats Up: 4 Late-Stage Therapies Poised to Redefine the Landscape
The GvHD drugs treatment landscape is undergoing a dynamic transformation, driven by a wave of innovation aimed at improving patient outcomes and quality of life. Once dominated by steroids and broad immunosuppressants, the field is now witnessing a surge in targeted therapies, cellular approaches, and novel biolog...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
